BioXcel Therapeutics Inc BTAI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:01 AM EDT
2.19quote price arrow up+0.10 (+5.02%)
Volume
119,605
52 week range
1.91 - 28.46
Loading...
  • Open2.15
  • Day High2.20
  • Day Low2.13
  • Prev Close2.09
  • 52 Week High28.46
  • 52 Week High Date05/16/23
  • 52 Week Low1.91
  • 52 Week Low Date02/09/24

Key Stats

  • Market Cap82.38M
  • Shares Out37.53M
  • 10 Day Average Volume0.45M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change-26.78

KEY STATS

  • Open2.15
  • Day High2.20
  • Day Low2.13
  • Prev Close2.09
  • 52 Week High28.46
  • 52 Week High Date05/16/23
  • 52 Week Low1.91
  • 52 Week Low Date02/09/24
  • Market Cap82.38M
  • Shares Out37.53M
  • 10 Day Average Volume0.45M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change-26.78

RATIOS/PROFITABILITY

  • EPS (TTM)-5.18
  • P/E (TTM)-0.42
  • Fwd P/E (NTM)-0.80
  • EBITDA (TTM)-140.27M
  • ROE (TTM)-1,766.94%
  • Revenue (TTM)1.756M
  • Gross Margin (TTM)24.15%
  • Net Margin (TTM)-8,715.72%
  • Debt To Equity (MRQ)-140.45%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioXcel Therapeutics Inc

 

Profile

MORE
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics, develops medicines in immuno-oncology. The Company’s most advanced neuroscience candidate, BXCL501, is an investigational, proprietary, orally dissolving film formulation of Dex in development for the treatment of agitation associated with psychiatric and neurological disorders. It is continuing to develop...
Peter Mueller Ph.D.
Independent Chairman of the Board
Vimal Mehta Ph.D.
President, Chief Executive Officer, Director
Richard Steinhart
Chief Financial Officer, Senior Vice President
Vincent O'Neill M.D.
Executive Vice President, Chief of Product Development and Medical Officer
Address
555 Long Wharf Dr
New Haven, CT
06511-6107
United States

Top Peers

SYMBOLLASTCHG%CHG
ANIX
Anixa Biosciences Inc
3.00UNCHUNCH
MIST
Milestone Pharmaceuticals Inc
1.72+0.02+1.17%
IOBT
IO Biotech Inc
1.45+0.02+1.40%
ELTX
Elicio Therapeutics Inc
9.56+0.15+1.59%
ALVR
Allovir Inc
0.7945+0.009+1.1458%